Cargando…
‘Longing’ for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing
Liquid biopsy using cell-free DNA (cfDNA) has gained global interest as a molecular diagnostic tool. However, the analysis of cfDNA in cancer patients and pregnant women has been focused on short DNA molecules (e.g., ≤ 600 bp). With the detection of long cfDNA in the plasma of pregnant women and can...
Autores principales: | Yu, Stephanie C. Y., Choy, L. Y. Lois, Lo, Y. M. Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435595/ https://www.ncbi.nlm.nih.gov/pubmed/37474843 http://dx.doi.org/10.1007/s40291-023-00661-2 |
Ejemplares similares
-
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?
por: Underhill, Hunter R.
Publicado: (2021) -
Ethical Hurdles in the Prioritization of Oncology Care
por: de Groot, Folkert, et al.
Publicado: (2016) -
Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016) -
MicroRNAs and Long Non-coding RNAs in Genetic Diseases
por: Finotti, Alessia, et al.
Publicado: (2019) -
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)